Download Citation
Article Source:
Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease
Cremer S,
Pilgram L,
Berkowitsch A,
Stecher M,
Rieg S,
et al.
(2021)
Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease.
PLOS ONE 16(10): e0258684.
https://doi.org/10.1371/journal.pone.0258684